Supplementary Figure from Cabozantinib Plus Nivolumab Phase I Expansion Study in Patients with Metastatic Urothelial Carcinoma Refractory to Immune Checkpoint Inhibitor Therapy Daniel M. Girardi , Scot A. Niglio , Amir Mortazavi , Rosa Nadal , Primo Lara , Sumanta K. Pal , Biren Saraiya , Lisa Cordes , Lisa Ley , Olena Sierra Ortiz , Jacqueline Cadena , Carlos Diaz , Hadi Bagheri , Bernadette Redd , Seth M. Steinberg , Rene Costello , Keith S. Chan , Min-Jung Lee , Sunmin Lee , Yunkai Yu , Sandeep Gurram , Heather J. Chalfin , Vladimir Valera , William D. Figg , Maria Merino , Antoun Toubaji , Howard Streicher , John J. Wright , Elad Sharon , Howard L. Parnes , Yang-Min Ning , Donald P. Bottaro , Liang Cao , Jane B. Trepel , Andrea B. Apolo pubmed（2023）
关键词
Neoadjuvant Therapy, Combination Therapies, Biomarkers for Immunotherapy, Urothelial Carcinoma
AI 理解论文
溯源树
样例
